Contract Pharma Staff08.18.20
Swiss American CDMO, a Dallas-based company that specializes in topical skin care, OTC drugs, medical devices and wound care products, was ranked No. 3290 on the 2020 Inc. 5000 list.
The 2020 list recognizes revenue growth from 2016-2019 among US-based, privately held, independent companies. Swiss-American was one of six skin care/personal care manufacturers to make the list, and the only Texas-based skin care/personal care manufacturer.
“We are honored to be recognized on the notable Inc. 5000 list for the second consecutive year," said Philip O’Neill, CEO of Swiss-American. “This recognition is a testament to our dedicated team of experts who remain at the forefront of the CDMO industry, identifying advanced topical solutions for a variety of disease states, therapeutic areas and global marketplaces.”
Swiss American CDMO partners with multinational customers to develop and manufacture topical sun, skin and wound care products in the over-the counter (OTC) drug, medical device and personal care markets. The company generated a compound annual growth rate of more than 29% over the past three years. While the new Inc. 5000 list does not reflect this year’s revenue data, the global pandemic created new challenges for all businesses in 2020. As a high-performing, fast-growth company, Swiss-American has learned to adapt to rapidly changing business circumstances.
“Swiss American CDMO is thankful for our network of customers that enabled our 2016-2019 growth and extremely proud to have continued our business operations uninterrupted, as an essential business, throughout 2020,” said Komel Grover, president of Swiss-American. “We continue to adapt and learn in these unprecedented times by applying our expertise to new areas of development to service the needs of new and existing customers. We continue to innovate and prepare for the future, so we can address the post-COVID-19 marketplace and consumer needs effectively for our customers. We stand ready for the future.”
Over the past decade, this is the third time Swiss American CDMO has been included in the annual Inc. 5000 ranking.
The 2020 list recognizes revenue growth from 2016-2019 among US-based, privately held, independent companies. Swiss-American was one of six skin care/personal care manufacturers to make the list, and the only Texas-based skin care/personal care manufacturer.
“We are honored to be recognized on the notable Inc. 5000 list for the second consecutive year," said Philip O’Neill, CEO of Swiss-American. “This recognition is a testament to our dedicated team of experts who remain at the forefront of the CDMO industry, identifying advanced topical solutions for a variety of disease states, therapeutic areas and global marketplaces.”
Swiss American CDMO partners with multinational customers to develop and manufacture topical sun, skin and wound care products in the over-the counter (OTC) drug, medical device and personal care markets. The company generated a compound annual growth rate of more than 29% over the past three years. While the new Inc. 5000 list does not reflect this year’s revenue data, the global pandemic created new challenges for all businesses in 2020. As a high-performing, fast-growth company, Swiss-American has learned to adapt to rapidly changing business circumstances.
“Swiss American CDMO is thankful for our network of customers that enabled our 2016-2019 growth and extremely proud to have continued our business operations uninterrupted, as an essential business, throughout 2020,” said Komel Grover, president of Swiss-American. “We continue to adapt and learn in these unprecedented times by applying our expertise to new areas of development to service the needs of new and existing customers. We continue to innovate and prepare for the future, so we can address the post-COVID-19 marketplace and consumer needs effectively for our customers. We stand ready for the future.”
Over the past decade, this is the third time Swiss American CDMO has been included in the annual Inc. 5000 ranking.
